🎉 M&A multiples are live!
Check it out!

Aroa Biosurgery Valuation Multiples

Discover revenue and EBITDA valuation multiples for Aroa Biosurgery and similar public comparables like Myomo, InfuSystem, and SmartVest.

Aroa Biosurgery Overview

About Aroa Biosurgery

Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.


Founded

2007

HQ

Australia
Employees

287

Website

aroa.com

Financials

LTM Revenue $42.3M

LTM EBITDA $1.1M

EV

$101M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Aroa Biosurgery Financials

Aroa Biosurgery has a last 12-month revenue of $42.3M and a last 12-month EBITDA of $1.1M.

In the most recent fiscal year, Aroa Biosurgery achieved revenue of $40.1M and an EBITDA of -$2.8M.

Aroa Biosurgery expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Aroa Biosurgery valuation multiples based on analyst estimates

Aroa Biosurgery P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $37.5M $40.1M XXX XXX XXX
Gross Profit $17.8M $31.7M XXX XXX XXX
Gross Margin 47% 79% XXX XXX XXX
EBITDA $2.0M -$2.8M XXX XXX XXX
EBITDA Margin 5% -7% XXX XXX XXX
Net Profit -$4.9M -$0.2M XXX XXX XXX
Net Margin -13% -1% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Aroa Biosurgery Stock Performance

As of March 14, 2025, Aroa Biosurgery's stock price is AUD 0 (or $0).

Aroa Biosurgery has current market cap of AUD 173M (or $109M), and EV of AUD 159M (or $101M).

See Aroa Biosurgery trading valuation data

Aroa Biosurgery Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$101M $109M XXX XXX XXX XXX $-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Aroa Biosurgery Valuation Multiples

As of March 14, 2025, Aroa Biosurgery has market cap of $109M and EV of $101M.

Aroa Biosurgery's trades at 2.2x LTM EV/Revenue multiple, and 80.6x LTM EBITDA.

Analysts estimate Aroa Biosurgery's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Aroa Biosurgery and 10K+ public comps

Aroa Biosurgery Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $101M XXX XXX XXX
EV/Revenue 2.2x XXX XXX XXX
EV/EBITDA 293.0x XXX XXX XXX
P/E -46.6x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -34.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Aroa Biosurgery Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Aroa Biosurgery Valuation Multiples

Aroa Biosurgery's NTM/LTM revenue growth is 23%

Aroa Biosurgery's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Aroa Biosurgery's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Aroa Biosurgery's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Aroa Biosurgery and other 10K+ public comps

Aroa Biosurgery Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 7% XXX XXX XXX XXX
EBITDA Margin 1% XXX XXX XXX XXX
EBITDA Growth -235% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 24% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue 90% XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 13% XXX XXX XXX XXX
Opex to Revenue 110% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Aroa Biosurgery Public Comps

See public comps and valuation multiples for Medical Devices and Regenerative Medicine comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Aroa Biosurgery M&A and Investment Activity

Aroa Biosurgery acquired  XXX companies to date.

Last acquisition by Aroa Biosurgery was  XXXXXXXX, XXXXX XXXXX XXXXXX . Aroa Biosurgery acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Aroa Biosurgery

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Aroa Biosurgery

When was Aroa Biosurgery founded? Aroa Biosurgery was founded in 2007.
Where is Aroa Biosurgery headquartered? Aroa Biosurgery is headquartered in Australia.
How many employees does Aroa Biosurgery have? As of today, Aroa Biosurgery has 287 employees.
Is Aroa Biosurgery publicy listed? Yes, Aroa Biosurgery is a public company listed on ASX.
What is the stock symbol of Aroa Biosurgery? Aroa Biosurgery trades under ARX ticker.
When did Aroa Biosurgery go public? Aroa Biosurgery went public in 2020.
Who are competitors of Aroa Biosurgery? Similar companies to Aroa Biosurgery include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Aroa Biosurgery? Aroa Biosurgery's current market cap is $109M
What is the current revenue of Aroa Biosurgery? Aroa Biosurgery's last 12-month revenue is $42.3M.
What is the current EBITDA of Aroa Biosurgery? Aroa Biosurgery's last 12-month EBITDA is $1.1M.
What is the current EV/Revenue multiple of Aroa Biosurgery? Current revenue multiple of Aroa Biosurgery is 2.2x.
What is the current EV/EBITDA multiple of Aroa Biosurgery? Current EBITDA multiple of Aroa Biosurgery is 80.6x.
What is the current revenue growth of Aroa Biosurgery? Aroa Biosurgery revenue growth between 2023 and 2024 was 7%.
Is Aroa Biosurgery profitable? Yes, Aroa Biosurgery is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.